Topping our list is global health care giant Merck & Co., which provides medicines, vaccines and animal health products. The company has the second-highest market cap on our list at US$214.1-billion. The company’s stock price has been quite stable over the past year, with a gain of 10 per cent year-to-date and 17.3 per cent over one year, making it one of the best performing stocks on our list. The stock has a current P/E of 12.9 and a dividend yield of 3.3 per cent.
Target Corp., a general merchandise and food retailer, just announced plans to hire an additional 100,000 workers for the holiday season as the company plans to sell holiday merchandise earlier than in previous years as the company is predicting shoppers will spend early to avoid higher costs closer to year-end owing to inflation pressures. The stock has a current P/E of 18 and a dividend yield of 2.7. Looking at stock performance, the stock price is down 34.
Walgreens Boots Alliance Inc., a holding company in the U.S. that operates a chain of pharmacies and various retail stores, has the lowest P/E on our list at just 5.7, and the highest dividend yield, 5.7 per cent. The stock just posted a new 12-month low. Trading Central Strategy Builder provides a back-testing capability to evaluate how well an investing strategy would have worked in the past. Using a three-year historical period with quarterly rebalancing, the screen described outperformed the benchmark with a 50-per-cent cumulative total return, compared with 31 per cent for the S&P 500.
The investment ideas presented here are for information only. They do not constitute advice or a recommendation by Trading Central in respect of the investment in financial instruments. Investors should conduct further research before investing.
Great. Vampire blood banks are doing really well too. I suppose the mop and pail will endorse that industry